Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Argus Health
QuintilesIMS
Citi
UBS
Chubb
Express Scripts
McKinsey
Julphar

Generated: February 18, 2019

DrugPatentWatch Database Preview

DAURISMO Drug Profile

« Back to Dashboard

Which patents cover Daurismo, and what generic alternatives are available?

Daurismo is a drug marketed by Pfizer Inc and is included in one NDA.

The generic ingredient in DAURISMO is glasdegib. One supplier is listed for this compound. Additional details are available on the glasdegib profile page.

Summary for DAURISMO
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
DailyMed Link:DAURISMO at DailyMed
Drug patent expirations by year for DAURISMO
Generic Entry Opportunity Date for DAURISMO
Generic Entry Date for DAURISMO*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for DAURISMO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc DAURISMO glasdegib TABLET;ORAL 210656-001 Nov 21, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer Inc DAURISMO glasdegib TABLET;ORAL 210656-002 Nov 21, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fuji
US Army
Merck
Daiichi Sankyo
Argus Health
UBS
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.